Mankind Pharma allots 46,582 shares under ESOP plan

Mankind Pharma Limited's nomination and remuneration committee approved the allotment of 46,582 equity shares on November 26, 2025, under its Employee Stock Option Plan 2022. Each share has a face value of ₹1 and an exercise price of ₹860.00 per equity share, with a premium of ₹859.00 per equity share.

This allotment increases the company's paid-up share capital from 41,27,58,490 equity shares to 41,28,05,072 equity shares. The newly allotted shares will rank pari-passu with the existing equity shares of the company.

The shares are listed on the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE). The filing date for the statement related to SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 was September 27, 2023.